AI-Based Pharma Co. Faces Investor Suit Over Study Woes
By Emilie Ruscoe ( July 10, 2023, 5:09 PM EDT) -- Artificial intelligence-driven biopharmaceutical company BioXcel Therapeutics Inc. has been hit with a proposed shareholder class action accusing the company of failing to disclose stumbles that allegedly affected the integrity of a study of a drug for agitated seniors with dementia....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.